Daclatasvir and asunaprevir treatment in patients infected by genotype 1b of hepatitis C virus with no or subtle resistant associated substitutions (RAS) in NS5A-Y93
- Masatoshi Ishigami
- , Kazuhiko Hayashi
- , Takashi Honda
- , Teiji Kuzuya
- , Yoji Ishizu
- , Tetsuya Ishikawa
- , Isao Nakano
- , Fumihiro Urano
- , Takashi Kumada
- , Kentaro Yoshioka
- , Yoshiki Hirooka
- , Hidemi Goto
研究成果: ジャーナルへの寄稿 › 学術論文 › 査読